Meta‐analysis shows that positive expression of PD‐L1 on circulating tumor cells predicts better survival prognosis in cancer patients treated with immune checkpoint inhibitors but unfavorable survival in those treated with other therapies. The gene discussed is CD274; the disease is neoplasm.